Skip to main content

Table 5 Multivariate analyss of overall survival.

From: Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis

 

P value

Hazard ratio

95% CI

Performance status

0.1

2.098

0.867 - 5.073

Tumor response

0.002

0.43

0.253 - 0.732

Second-line chemotherapy

0.573

0.855

0.495 - 1.476

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us